Pnc Financial Services Group, Inc. Pro Qr Therapeutics N.V. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 19,527 shares of PRQR stock, worth $42,764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,527
Previous 17,649
10.64%
Holding current value
$42,764
Previous $36,000
13.89%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRQR
# of Institutions
65Shares Held
38.3MCall Options Held
0Put Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA6.25MShares$13.7 Million0.02% of portfolio
-
Privium Fund Management B.V.5MShares$10.9 Million1.92% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.6MShares$7.88 Million0.88% of portfolio
-
Morgan Stanley New York, NY2.9MShares$6.35 Million0.0% of portfolio
-
Abrdn PLC2.3MShares$5.03 Million0.01% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $156M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...